MENU
+Compare
SGRY
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$21.22
Change
+$1.61 (+8.21%)
Capitalization
3.66B

SGRY stock forecast, quote, news & analysis

SGRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
A.I.Advisor
a Summary for SGRY with price predictions
Dec 20, 2024

SGRY sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for SGRY moved below the 200-day moving average on December 10, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 04, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on SGRY as a result. In of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SGRY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SGRY entered a downward trend on December 20, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SGRY's RSI Oscillator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for SGRY just turned positive on December 16, 2024. Looking at past instances where SGRY's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SGRY advanced for three days, in of 275 cases, the price rose further within the following month. The odds of a continued upward trend are .

SGRY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SGRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SGRY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.840) is normal, around the industry mean (4.577). P/E Ratio (0.000) is within average values for comparable stocks, (71.885). SGRY's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.595). SGRY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.026). P/S Ratio (1.322) is also within normal values, averaging (21.067).

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 4.05B. The market cap for tickers in the group ranges from 1.86K to 88.21B. HCA holds the highest valuation in this group at 88.21B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was -4%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 0%. NVLPF experienced the highest price growth at 11%, while JXFGF experienced the biggest fall at -43%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was 140%. For the same stocks of the Industry, the average monthly volume growth was 54% and the average quarterly volume growth was 19%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 72
Price Growth Rating: 58
SMR Rating: 79
Profit Risk Rating: 82
Seasonality Score: 24 (-100 ... +100)
View a ticker or compare two or three
SGRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a company which engages in health care services

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Hospital Or Nursing Management
Address
340 Seven Springs Way
Phone
+1 615 234-5900
Employees
13500
Web
https://www.surgerypartners.com